Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

FUISZ Announces Advances in Devices and Solid Dosage Form

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

MIAMI , July 1 /- FUISZ today announced two medical technology advances. First, FUISZ announced that it has received a notice of issuance from the United States Patent and Trademark Office for patent claims that cover a direct connection between prescribing physicians and blood analysis...

TOPICS:

Par Pharmaceutical Begins Shipment of Generic Zegerid®

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

WOODCLIFF LAKE, N.J. , July 1 /- Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that it began shipping the 20mg/1100mg and 40mg/1100mg strengths of omeprazole and sodium bicarbonate capsules to the trade. Omeprazole and sodium bicarbonate capsules are the generic version...

TOPICS:

FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP

July 1, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

SCHAUMBURG, Ill. , July 1 /- Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's nine presentations of heparin sodium injection, USP. Heparin is a vital anticoagulant,...

TOPICS:
Advertisement

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology

July 1, 2010 5:33 am | by IBM | News | Comments

YORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology that will directly read and sequence human DNA quickly and efficiently. Focused on...

TOPICS:

Endo Pharmaceuticals Completes Next Step in Regulatory Process for FORTESTAâ„¢ for Men With Low Testosterone

July 1, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa. , July 1 /- Endo Pharmaceuticals (Nasdaq: ENDP ) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for...

TOPICS:

July/August 2010 Digital Edition

July 1, 2010 12:00 am | Digital Editions | Comments

Inside: Read about asking the right questions about high performance plastic from micromolding an MIS device in “The Critical Questions When Micromolding for an MIS Device,” from Mikrotech. Shared are professionals’ opinions on FDA review process and wireless medical technology. Additionally, read about lasers for orthopedics, 3D imaging, package testing, sensors, testing, and Petri dish diagnostics.

Stem-cell therapy may provide new approach to fight infection

June 30, 2010 10:33 pm | by EurekAlert | News | Comments

(Ottawa Hospital Research Institute) A new study shows that treatment with mesenchymal stem cells can triple survival rates in mice with sepsis, a deadly condition that can occur when an infection spreads throughout the body. The treatment reduced the damaging effects of...

TOPICS:

Planned home births associated with tripling of neonatal mortality rate vs. planned hospital births

June 30, 2010 10:33 pm | by EurekAlert | News | Comments

(Elsevier Health Sciences) In a study published online today by the American Journal of Obstetrics & Gynecology, researchers from Maine Medical Center, Portland, Maine, analyzed the results of multiple studies from around the world. They report that less medical intervention,...

TOPICS:
Advertisement

AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise

June 30, 2010 10:33 pm | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) Today, the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) announced the release of a consensus statement to address ambiguities and disparities in the diagnosis and management of nasal valve compromise (NVC).

TOPICS:

Drug Device for Hearing Loss

June 30, 2010 8:38 pm | by Massachusetts Institute of Technology | News | Comments

An implant could deliver drugs directly to the cochlea.

Brookwood Medical clears construction hurdle

June 30, 2010 3:45 pm | by The Associated Press | News | Comments

A judge says Brookwood Medical Center should be allowed to build Alabama's first freestanding emergency department near the intersection of U.S. 280 and Alabama 119.An administrative law judge made the ruling Wednesday. The issue now goes before the state Certificate of Need board, which meets...

Charleston man pleads guilty in embezzlement

June 30, 2010 2:45 pm | by The Associated Press | News | Comments

A Charleston investment adviser has pleaded guilty to embezzling from a company's employee benefit plan.The federal prosecutor's office says 50-year-old Knox Fuqua entered his plea before U.S. District Judge John T. Copenhaver Jr. on Wednesday. Fuqua faces up to five years in prison when he is...

US plan to pay hospitals for performance could hurt those in less-advantaged areas

June 30, 2010 2:38 pm | by EurekAlert | News | Comments

(New York University) The nationwide implementation of hospital pay-for-performance threatens to act as a "reverse Robin Hood," according to a New York University-led study published in the academic journal PLoS Medicine on June 29, 2010.

TOPICS:

MarSurf UD 120 Measures Surface and Contour in Single Pass

June 30, 2010 12:41 pm | Product Releases | Comments

The new MarSurf UD 120 from Mahr Federal can generate both surface and contour measurements in a single pass. The system provides high accuracy over a large measuring range in nanometer resolutions.

SMOS shines at symposium

June 30, 2010 12:36 pm | by EurekAlert | News | Comments

(European Space Agency) Today, a focus at ESA's Living Planet Symposium is on the innovative SMOS mission, which recently became operational. Early results are proving very encouraging with its first observations due to be released in early July.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading